SABBY MANAGEMENT LLC 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-03 5:57 pm Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 30,191 11.000% | -219,809 (-87.92%) | Filing |
| 2021-02-19 2:45 pm Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 250,000 11.000% | 220,833 (+757.14%) | Filing |
| 2021-01-07 1:38 pm Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 29,167 11.000% | -70,854 (-70.84%) | Filing |
| 2020-12-01 8:48 pm Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | SABBY MANAGEMENT LLC | 100,021 11.000% | 100,021 (New Position) | Filing |